Amylyx Pharmaceuticals Inc (AMLX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
3,763,707,000
EV to revenue ratio (TTM)
6,446.63
EV to ebitda
-11.71
Financial Performance
Revenue (TTM)
-665,000
Gross profit (TTM)
-92,447,000
EBITDA
-161,734,000
Profitability
Operating margin (TTM)
0.00%
Profit margin
0.00%
Return on assets (TTM)
-44.10%
Return on equity (TTM)
-74.70%
Per Share Metrics
Revenue per share (TTM)
-0.01
EPS
-1.41
Diluted EPS (TTM)
-1.41
Book value
2.15
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
2.774
PEG ratio
Price to sales ratio (TTM)
0.662
Price to book ratio (TTM)
17.32
Growth
Quarterly earnings growth (YoY)
-99.60%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
0
Buy
10
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
-0.119